Address: Karolinska Institutet, Dept of Biosciences and Nutrition, 141 57 Huddinge
| 1988 | B.Sc. Biochemistry & Microbiology, University of Stockholm. |
| 1992 | Ph.D. Karolinska Institutet. Area: Experimental Pathology. Thesis entitled: “The epidermal growth factor receptor system in rat liver growth and carcinogenesis”. |
| 1994-1996 | Post-doctoral training, The Scripps Research Institute, La Jolla, CA, in the laboratory of Dr. David A. Cheresh. Area: Integrins and angiogenesis. |
| 2003-2009 | Senior scientist position (6 years) by the Swedish Research Council. |
| 2000 | Associate professor (docent), Karolinska Institutet. |
| 1997 | Principal investigator and Assistant professor, Karolinska Institutet. |
| 1997-2003 | Cancer researcher position by The Swedish Cancer Society. |
| 1994-1996 | Research associate, The Scripps Research Institute (3 yrs). |
| 1993 | Post-doctoral researcher, Karolinska Institutet. |
| 1988-1992 | Post-graduate student, Karolinska Institutet. |
Wenjie Bao, PhD 2005-06-17; Annica Gad, PhD 2005-08-26. Totally eleven different post-doctoral fellows have worked under my supervision 1998-2006. I am presently main supervisor for 3 PhD students, and co-supervisor of 4.
| 2007 | Erik K. Fernström’s prize for young investigators, University of Lund, Sweden |
| 2004 | Awarded the KI-Cancer strategic grant |
| 2003 | Senior scientist Award position in Clinical Molecular Biology from the Swedish Research Council |
| 1996 | The Wenner-Gren Foundation post-doctoral fellowship |
| 1994-95 | The Swedish Cancer Society post-doctoral fellowship |
| - | Deputy chairman of evaluation committee PKB1 (study section) at the Swedish Cancer Society 2008- . |
| - | Member of an international evaluation board for Academy of Finland; yearly evaluations 2007- . |
| - | Member of evaluation committee PKB (study section) at the Swedish Cancer Society 2006 - . |
| - | Board member of the KI-Cancer network 2004-2006. |
| - | Chairman of the review committee for the Robert Lundberg memorial foundation 2002-2005. |
| - | Member of the department/division boards during various periods, 1988-1992 and 1997-2004. |
| - | A long number of commissions of trust within academia as a student, including as vice president of the Federation of the Student Unions of Stockholm (SSCO) 1987-88, board member of the Stockholm Student Housing Foundation (SSSB) 1987-91 and of the Stockholm Students Sports Federation 1986-91, board member of the Stockholm University Student Union 1987-88 and Chairman of the Student health care organization in Stockholm (Studenthälsan)1987-88. |
| - | Faculty opponent at two PhD dissertations (Tallin Technical University, Estonia, 2000; Turku University, Finland, 2005) and one licenciate dissertation (Stockholm University, Sweden, 2005). |
| - | Assignments as ad hoc reviewer for the following journals; Artheroscl. Thrombosis Vascul. Biol.; Am. J. Pathol.; Blood; Cancer Lett.; Cell; Exp. Cell Res.; FASEB J.; J. Cell Biol.; J. Cell Sci.; J. Clin. Invest.; Mol. Biol. Cell; Proc. Natl. Acad. Sci. USA; Trends Cell Biol.; Trends Mol. Med. |
| - | Co-founder of two start-up biotech companies within the Oncology field; Angitia AB and Aprea AB, both in operation. |
| - | Author of two patent applications. |
My scientific papers have been cited a total of more than 2700 times (ISI, May, 2008).
| - | Invited speaker at approximately fifteen international conferences/symposia, including as a Keynote speaker at the annual meeting of the Dutch working party for tumor biology, Lunteren, The Netherlands, May 6-7, 1996. |
| - | Invited speaker at approximately twenty foreign institutes, universities, etc. |
| - | Organizer of an international symposium on Angiogenesis at Nobel Forum, Karolinska Institutet, September 1997. |
| - | Organizer of a Minisymposium on Fluorescent live cell imaging at Karolinska Institutet, February 2004. |
| 1. | Strömblad, S., Becker, J.C., Yebra, M., Brooks, P.C. & Cheresh, D.A. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin aVß3 during angiogenesis. J. Clin. Invest. 98, 426-433 (1996). |
| 2. | Zhang, H., Li, Z., Viklund, E-K. & Strömblad, S. p21-activated kinase 4 interacts with integrin avb5 and regulates avb5-mediated cell migration. J. Cell Biol. 158, 1287-1297 (2002). |
| 3. | Zhang, H., Berg, J., Li, Z., Wang, Y., Lång, P., Sousa, A.D., Bhaskar, A., Cheney, R.C. & Strömblad, S. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nature Cell Biol. 6, 523-531 (2004). |
| 4. | Bao, W. & Strömblad, S. Integrin av-mediated inactivation of p53 controls a MEK-1-dependent melanoma cell survival pathway in three-dimensional collagen. J. Cell Biol. 167, 745-756. (2004). |
| 5. | Thullberg, M., Gad, A., LeGuyader, S. & Strömblad, S. Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis. Proc Natl Acad Sci USA. 104, 20338-20343 (2007). |